~~<i id='6FF65D1C40'><strike id='6FF65D1C40'><tt id='6FF65D1C40'><pre id='6FF65D1C40'></pre></tt></strike></i>~~

Home» Wikipedia» entertainment

entertainment

author：entertainment 2025-09-30 15:04:14 Page View：639

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At JPM 2024, hospital systems pitch financial strength to investors
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

explore

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Was Amgen transparent enough on FDA's concern on cancer drug?

MarkJ.Terrill/APAmidthestunningrebukeAmgensufferedatthehandsoftheU.S.FoodandDrugAdministrationthiswe

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Nonprofit, backed by Microsoft, to certify AI tools in health care

AdobeAgroupofacademichospitalsandtechnologycompanieswillformanewnonprofitventuretooverseeanationwide